STRIDE INC (LRN) Fundamental Analysis & Valuation

NYSE:LRN • US86333M1080

84.95 USD
+0.35 (+0.41%)
Last: Mar 11, 2026, 11:09 AM

This LRN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Overall LRN gets a fundamental rating of 7 out of 10. We evaluated LRN against 74 industry peers in the Diversified Consumer Services industry. Both the health and profitability get an excellent rating, making LRN a very profitable company, without any liquidiy or solvency issues. LRN may be a bit undervalued, certainly considering the very reasonable score on growth This makes LRN very considerable for value and quality investing!


Dividend Valuation Growth Profitability Health

9

1. LRN Profitability Analysis

1.1 Basic Checks

  • In the past year LRN was profitable.
  • In the past year LRN had a positive cash flow from operations.
  • In the past 5 years LRN has always been profitable.
  • Each year in the past 5 years LRN had a positive operating cash flow.
LRN Yearly Net Income VS EBIT VS OCF VS FCFLRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • LRN has a better Return On Assets (13.83%) than 90.54% of its industry peers.
  • LRN's Return On Equity of 20.61% is amongst the best of the industry. LRN outperforms 86.49% of its industry peers.
  • LRN has a better Return On Invested Capital (16.82%) than 90.54% of its industry peers.
  • LRN had an Average Return On Invested Capital over the past 3 years of 11.97%. This is in line with the industry average of 10.83%.
  • The 3 year average ROIC (11.97%) for LRN is below the current ROIC(16.82%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.83%
ROE 20.61%
ROIC 16.82%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
LRN Yearly ROA, ROE, ROICLRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 12.66%, LRN belongs to the best of the industry, outperforming 82.43% of the companies in the same industry.
  • LRN's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 18.38%, LRN belongs to the top of the industry, outperforming 81.08% of the companies in the same industry.
  • In the last couple of years the Operating Margin of LRN has grown nicely.
  • LRN has a Gross Margin of 39.30%. This is comparable to the rest of the industry: LRN outperforms 44.59% of its industry peers.
  • LRN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.38%
PM (TTM) 12.66%
GM 39.3%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
LRN Yearly Profit, Operating, Gross MarginsLRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

8

2. LRN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LRN is creating value.
  • LRN has more shares outstanding than it did 1 year ago.
  • LRN has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for LRN has been reduced compared to a year ago.
LRN Yearly Shares OutstandingLRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
LRN Yearly Total Debt VS Total AssetsLRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • LRN has an Altman-Z score of 5.94. This indicates that LRN is financially healthy and has little risk of bankruptcy at the moment.
  • LRN's Altman-Z score of 5.94 is amongst the best of the industry. LRN outperforms 90.54% of its industry peers.
  • LRN has a debt to FCF ratio of 3.02. This is a good value and a sign of high solvency as LRN would need 3.02 years to pay back of all of its debts.
  • LRN has a Debt to FCF ratio of 3.02. This is in the better half of the industry: LRN outperforms 78.38% of its industry peers.
  • LRN has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • LRN has a Debt to Equity ratio of 0.31. This is comparable to the rest of the industry: LRN outperforms 56.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.02
Altman-Z 5.94
ROIC/WACC2.1
WACC8.01%
LRN Yearly LT Debt VS Equity VS FCFLRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

  • LRN has a Current Ratio of 7.27. This indicates that LRN is financially healthy and has no problem in meeting its short term obligations.
  • LRN's Current ratio of 7.27 is amongst the best of the industry. LRN outperforms 97.30% of its industry peers.
  • A Quick Ratio of 7.19 indicates that LRN has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 7.19, LRN belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.27
Quick Ratio 7.19
LRN Yearly Current Assets VS Current LiabilitesLRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

6

3. LRN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.03% over the past year.
  • The Earnings Per Share has been growing by 58.07% on average over the past years. This is a very strong growth
  • The Revenue has grown by 14.86% in the past year. This is quite good.
  • Measured over the past years, LRN shows a quite strong growth in Revenue. The Revenue has been growing by 18.24% on average per year.
EPS 1Y (TTM)16.03%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%23.15%
Revenue 1Y (TTM)14.86%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%7.5%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.78% on average over the next years. This is quite good.
  • LRN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.66% yearly.
EPS Next Y22.73%
EPS Next 2Y14.4%
EPS Next 3Y12.78%
EPS Next 5YN/A
Revenue Next Year6.51%
Revenue Next 2Y5.62%
Revenue Next 3Y5.4%
Revenue Next 5Y5.66%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LRN Yearly Revenue VS EstimatesLRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
LRN Yearly EPS VS EstimatesLRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

8

4. LRN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.22 indicates a correct valuation of LRN.
  • 78.38% of the companies in the same industry are more expensive than LRN, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of LRN to the average of the S&P500 Index (26.25), we can say LRN is valued rather cheaply.
  • A Price/Forward Earnings ratio of 10.78 indicates a reasonable valuation of LRN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LRN indicates a rather cheap valuation: LRN is cheaper than 86.49% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of LRN to the average of the S&P500 Index (24.39), we can say LRN is valued rather cheaply.
Industry RankSector Rank
PE 12.22
Fwd PE 10.78
LRN Price Earnings VS Forward Price EarningsLRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • LRN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LRN is cheaper than 83.78% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, LRN is valued a bit cheaper than the industry average as 66.22% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 20.16
EV/EBITDA 5.82
LRN Per share dataLRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • LRN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of LRN may justify a higher PE ratio.
  • A more expensive valuation may be justified as LRN's earnings are expected to grow with 12.78% in the coming years.
PEG (NY)0.54
PEG (5Y)0.21
EPS Next 2Y14.4%
EPS Next 3Y12.78%

0

5. LRN Dividend Analysis

5.1 Amount

  • No dividends for LRN!.
Industry RankSector Rank
Dividend Yield 0%

LRN Fundamentals: All Metrics, Ratios and Statistics

STRIDE INC

NYSE:LRN (3/11/2026, 11:09:12 AM)

84.95

+0.35 (+0.41%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)01-27
Earnings (Next)04-27
Inst Owners110.17%
Inst Owner Change-1.77%
Ins Owners3.1%
Ins Owner Change1.48%
Market Cap3.62B
Revenue(TTM)2.52B
Net Income(TTM)318.94M
Analysts82
Price Target128.01 (50.69%)
Short Float %15.22%
Short Ratio4.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.44%
Min EPS beat(2)18.86%
Max EPS beat(2)26.01%
EPS beat(4)2
Avg EPS beat(4)0.71%
Min EPS beat(4)-41.53%
Max EPS beat(4)26.01%
EPS beat(8)6
Avg EPS beat(8)44.91%
EPS beat(12)10
Avg EPS beat(12)45.21%
EPS beat(16)13
Avg EPS beat(16)17.55%
Revenue beat(2)1
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.46%
Max Revenue beat(2)0.16%
Revenue beat(4)3
Avg Revenue beat(4)1.49%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.34%
Revenue beat(8)7
Avg Revenue beat(8)2.32%
Revenue beat(12)10
Avg Revenue beat(12)2.47%
Revenue beat(16)14
Avg Revenue beat(16)2.55%
PT rev (1m)-2.81%
PT rev (3m)-5.01%
EPS NQ rev (1m)0.25%
EPS NQ rev (3m)3.73%
EPS NY rev (1m)1.46%
EPS NY rev (3m)1.64%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)2.59%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.51%
Valuation
Industry RankSector Rank
PE 12.22
Fwd PE 10.78
P/S 1.44
P/FCF 20.16
P/OCF 14.61
P/B 2.34
P/tB 3.15
EV/EBITDA 5.82
EPS(TTM)6.95
EY8.18%
EPS(NY)7.88
Fwd EY9.27%
FCF(TTM)4.21
FCFY4.96%
OCF(TTM)5.81
OCFY6.84%
SpS59.16
BVpS36.35
TBVpS26.93
PEG (NY)0.54
PEG (5Y)0.21
Graham Number75.4
Profitability
Industry RankSector Rank
ROA 13.83%
ROE 20.61%
ROCE 22.19%
ROIC 16.82%
ROICexc 24.03%
ROICexgc 33.13%
OM 18.38%
PM (TTM) 12.66%
GM 39.3%
FCFM 7.12%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
ROICexc(3y)20.97%
ROICexc(5y)16.99%
ROICexgc(3y)36.26%
ROICexgc(5y)30.39%
ROCE(3y)15.79%
ROCE(5y)13.55%
ROICexgc growth 3Y30.19%
ROICexgc growth 5Y48.22%
ROICexc growth 3Y36.36%
ROICexc growth 5Y54.51%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
F-Score7
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.02
Debt/EBITDA 0.83
Cap/Depr 57.06%
Cap/Sales 2.7%
Interest Coverage 44.37
Cash Conversion 42.51%
Profit Quality 56.26%
Current Ratio 7.27
Quick Ratio 7.19
Altman-Z 5.94
F-Score7
WACC8.01%
ROIC/WACC2.1
Cap/Depr(3y)56.69%
Cap/Depr(5y)59.43%
Cap/Sales(3y)3.07%
Cap/Sales(5y)3.32%
Profit Quality(3y)114.14%
Profit Quality(5y)117.4%
High Growth Momentum
Growth
EPS 1Y (TTM)16.03%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%23.15%
EPS Next Y22.73%
EPS Next 2Y14.4%
EPS Next 3Y12.78%
EPS Next 5YN/A
Revenue 1Y (TTM)14.86%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%7.5%
Revenue Next Year6.51%
Revenue Next 2Y5.62%
Revenue Next 3Y5.4%
Revenue Next 5Y5.66%
EBIT growth 1Y38.43%
EBIT growth 3Y38.88%
EBIT growth 5Y66.8%
EBIT Next Year37.23%
EBIT Next 3Y12.15%
EBIT Next 5Y18.08%
FCF growth 1Y13.3%
FCF growth 3Y38.85%
FCF growth 5Y60.14%
OCF growth 1Y12.51%
OCF growth 3Y27.9%
OCF growth 5Y40.03%

STRIDE INC / LRN FAQ

What is the ChartMill fundamental rating of STRIDE INC (LRN) stock?

ChartMill assigns a fundamental rating of 7 / 10 to LRN.


What is the valuation status of STRIDE INC (LRN) stock?

ChartMill assigns a valuation rating of 8 / 10 to STRIDE INC (LRN). This can be considered as Undervalued.


How profitable is STRIDE INC (LRN) stock?

STRIDE INC (LRN) has a profitability rating of 9 / 10.


What is the expected EPS growth for STRIDE INC (LRN) stock?

The Earnings per Share (EPS) of STRIDE INC (LRN) is expected to grow by 22.73% in the next year.


Can you provide the dividend sustainability for LRN stock?

The dividend rating of STRIDE INC (LRN) is 0 / 10 and the dividend payout ratio is 0%.